(HOV) Hovnanian Enterprises - Overview
Stock: Homes, Townhomes, Condominiums, Mortgages, Title
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 67.0% |
| Relative Tail Risk | -7.97% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.19 |
| Alpha | -23.45 |
| Character TTM | |
|---|---|
| Beta | 1.289 |
| Beta Downside | 0.610 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.12% |
| CAGR/Max DD | 0.39 |
Description: HOV Hovnanian Enterprises December 26, 2025
Hovnanian Enterprises, Inc. (NYSE:HOV) designs, builds, markets, and sells a range of residential properties across the United States, including single-family detached homes, townhomes, condominiums, and urban-infill “active-lifestyle” communities that feature amenities such as clubhouses, pools, and tennis courts. The company serves a broad buyer spectrum-from first-time and move-up purchasers to luxury, active-lifestyle, and empty-nest buyers-and also offers ancillary services like mortgage financing and title processing. Founded in 1959, HOV is headquartered in Matawan, New Jersey, and operates within the GICS Homebuilding sub-industry.
Key recent metrics: FY 2023 revenue was approximately $2.2 billion, with around 7,200 homes delivered-a 5 % increase YoY; the average selling price (ASP) rose to roughly $400 k, reflecting both product mix upgrades and regional price trends. The homebuilder’s inventory turnover sits near 6 months, while its mortgage-originating segment contributed about 3 % of total earnings, underscoring sensitivity to the Federal Reserve’s benchmark rate. Sector-wide, the homebuilding outlook remains tied to housing-starts data, labor-cost pressures, and the trajectory of construction-material prices, especially lumber and steel.
For a deeper quantitative dive, you might explore the ValueRay platform’s analyst tools and data visualizations.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 63.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 6.09 > 1.0 |
| NWC/Revenue: 21.64% < 20% (prev -3.55%; Δ 25.19% < -1%) |
| CFO/TA 0.08 > 3% & CFO 207.5m > Net Income 63.9m |
| Net Debt (-285.4m) to EBITDA (126.7m): -2.25 < 3 |
| Current Ratio: 2904 > 1.5 & < 3 |
| Outstanding Shares: last quarter (6.47m) vs 12m ago -7.82% < -2% |
| Gross Margin: 59.61% > 18% (prev 0.20%; Δ 5942 % > 0.5%) |
| Asset Turnover: 113.7% > 50% (prev 115.3%; Δ -1.60% > 0%) |
| Interest Coverage Ratio: 4.21 > 6 (EBITDA TTM 126.7m / Interest Expense TTM 26.8m) |
Altman Z'' 2.46
| A: 0.24 (Total Current Assets 644.7m - Total Current Liabilities 222.0k) / Total Assets 2.63b |
| B: 0.05 (Retained Earnings 127.3m / Total Assets 2.63b) |
| C: 0.04 (EBIT TTM 112.9m / Avg Total Assets 2.62b) |
| D: 0.39 (Book Value of Equity 695.6m / Total Liabilities 1.80b) |
| Altman-Z'' Score: 2.46 = A |
Beneish M -3.82
| DSRI: 0.91 (Receivables 26.5m/29.4m, Revenue 2.98b/3.00b) |
| GMI: 0.33 (GM 59.61% / 19.62%) |
| AQI: 0.92 (AQ_t 0.74 / AQ_t-1 0.80) |
| SGI: 0.99 (Revenue 2.98b / 3.00b) |
| TATA: -0.05 (NI 63.9m - CFO 207.5m) / TA 2.63b) |
| Beneish M-Score: -3.82 (Cap -4..+1) = AAA |
What is the price of HOV shares?
Over the past week, the price has changed by +11.74%, over one month by +25.43%, over three months by +4.68% and over the past year by -6.20%.
Is HOV a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HOV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 120 | -4.7% |
| Analysts Target Price | 120 | -4.7% |
| ValueRay Target Price | 137.8 | 9.5% |
HOV Fundamental Data Overview February 04, 2026
P/E Forward = 13.6426
P/S = 0.2232
P/B = 0.964
P/EG = 1.22
Revenue TTM = 2.98b USD
EBIT TTM = 112.9m USD
EBITDA TTM = 126.7m USD
Long Term Debt = 930.2m USD (from longTermDebt, last quarter)
Short Term Debt = 2.50m USD (from shortTermDebt, two quarters ago)
Debt = 930.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -285.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.32b USD (664.7m + Debt 930.2m - CCE 272.8m)
Interest Coverage Ratio = 4.21 (Ebit TTM 112.9m / Interest Expense TTM 26.8m)
EV/FCF = 7.96x (Enterprise Value 1.32b / FCF TTM 166.2m)
FCF Yield = 12.57% (FCF TTM 166.2m / Enterprise Value 1.32b)
FCF Margin = 5.58% (FCF TTM 166.2m / Revenue TTM 2.98b)
Net Margin = 2.14% (Net Income TTM 63.9m / Revenue TTM 2.98b)
Gross Margin = 59.61% ((Revenue TTM 2.98b - Cost of Revenue TTM 1.20b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.50 (Enterprise Value 1.32b / Total Assets 2.63b)
Interest Expense / Debt = 1.04% (Interest Expense 9.63m / Debt 930.2m)
Taxrate = 25.81% (22.2m / 86.1m)
NOPAT = 83.7m (EBIT 112.9m * (1 - 25.81%))
Current Ratio = 2904 (out of range, set to none) (Total Current Assets 644.7m / Total Current Liabilities 222.0k)
Debt / Equity = 1.12 (Debt 930.2m / totalStockholderEquity, last quarter 830.9m)
Debt / EBITDA = -2.25 (Net Debt -285.4m / EBITDA 126.7m)
Debt / FCF = -1.72 (Net Debt -285.4m / FCF TTM 166.2m)
Total Stockholder Equity = 824.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.44% (Net Income 63.9m / Total Assets 2.63b)
RoE = 7.75% (Net Income TTM 63.9m / Total Stockholder Equity 824.5m)
RoCE = 6.43% (EBIT 112.9m / Capital Employed (Equity 824.5m + L.T.Debt 930.2m))
RoIC = 5.13% (NOPAT 83.7m / Invested Capital 1.63b)
WACC = 4.89% (E(664.7m)/V(1.59b) * Re(10.66%) + D(930.2m)/V(1.59b) * Rd(1.04%) * (1-Tc(0.26)))
Discount Rate = 10.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.21%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈102.0m ; Y1≈125.8m ; Y5≈214.3m
Fair Price DCF = 1263 (EV 6.24b - Net Debt -285.4m = Equity 6.53b / Shares 5.17m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -64.39 | EPS CAGR: -44.12% | SUE: 1.12 | # QB: 1
Revenue Correlation: 33.07 | Revenue CAGR: 10.35% | SUE: 0.00 | # QB: 0
EPS next Quarter (2026-04-30): EPS=-0.29 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS current Year (2026-10-31): EPS=0.17 | Chg30d=-7.920 | Revisions Net=-1 | Growth EPS=-97.7% | Growth Revenue=+6.5%
EPS next Year (2027-10-31): EPS=4.21 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+2376.5% | Growth Revenue=+4.6%